Research in the department of pharmaceutics encompasses studies in pharmacokinetics, quantitative pharmacology, pharmacometrics, pharmaceutical analysis, pharmaceutical biotechnology and drug delivery.
Dr. Schmittgen’s research interests include cancer therapeutics, exosomes as targeted drug delivery systems and the role of noncoding RNAs in cancer initiation and progression.
Dr. Hochhaus’ research interests include the relationship between the drug and formulation properties of inhalation drugs, their pharmacokinetic and dynamic properties, and bioequivalence pharmacodynamic effects.
Dr. Mobley’s Research interests include application of instructional design principles to optimize student pharmacist learning and the application of critical thinking and reasoning skills to help develop problem-solving abilities.
Dr. Schmidt’s research interests include the application of quantitative analysis tools to address clinically relevant research questions in the areas of antimicrobial chemotherapy, pediatrics, diabetes, cardiovascular safety and postmenopausal osteoporosis.
Dr. Song’s research interests include adeno-associated virus, or AAV, vector biology, liver and muscle gene delivery, novel function of alpha 1 antitrypsin, or AAT, AAT deficiency and autoimmune and inflammatory diseases.
Dr. Vozmediano’s research interests include model-informed drug development for strategic decision making in special populations, implementation of pharmacometric-based regulatory strategies, and application of translational research to animal health.
Faculty in the department of pharmaceutics secured $6.2 million in research funding in 2018.
Creating a uniquely rigorous and integrative academic translational science program in quantitative clinical pharmacology with a focus on precision medicine.